Aug 12 (Reuters) - China Biotech Services Holdings Ltd
8037.HK :
* QTRLY PROFIT HK$99.8 MILLION VERSUS HK$81.8 MILLION
* QTRLY TURNOVER HK$302.8 MILLION VERSUS HK$220.0 MILLION
* GROUP EXPECTS DEMAND OF DIAGNOSTIC AND HEALTH CHECKUP
SERVICES
TO REMAIN STABLE IN SECOND HALF OF 2022
* SEES DEMAND FOR SELF-PAID NUCLEIC ACID TEST & OTHER
MEDICAL
DIAGNOSTIC SERVICES IS EXPECTED TO PICK UP
* CAUTIOUSLY OPTIMISTIC THAT GROUP'S PERFORMANCE WILL REMAIN
STABLE IN SECOND HALF OF 2022
Further company coverage: 8037.HK
((Reuters.Briefs@thomsonreuters.com;))